Product Description
Product introduction
Darzalex Injection is used in the treatment of multiple myeloma, which is a type of cancer of plasma cells.
Darzalex Injection is given as an IV infusion into veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Infusion reaction such as swollen face, lips, mouth, tongue or throat, difficulty swallowing or breathing are very common side effects. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells while taking this medicine.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Powerful Monoclonal Antibody Therapy for Multiple MyelomaDarzalex Daratumumab 100 mg Injection offers a targeted approach for treating multiple myeloma. By binding specifically to cancer cells, it empowers the immune system to fight malignancy. Its advanced formulation and proven efficacy have made it a pivotal addition to cancer immunotherapy, providing hope for improved clinical outcomes in eligible patients.
Optimal Administration and Storage ConditionsThis injection is intended for intravenous use under the supervision of a healthcare professional. To maintain product integrity, it should always be kept in its original carton to shield it from light and be refrigerated at 2C to 8C. Avoid freezing the product to ensure it retains its therapeutic benefits throughout its 24-month shelf life.
FAQ's of Darzalex Daratumumab 100 Mg Injection:
Q: How should Darzalex Daratumumab 100 mg Injection be administered?
A: This medication is administered intravenously (IV) by a qualified healthcare provider. The contents must first be diluted with 0.9% sodium chloride injection before infusion. Dosage and treatment schedule will be determined by your doctor based on individual treatment needs.
Q: What is the main benefit of using Darzalex in multiple myeloma treatment?
A: Darzalex helps target and destroy multiple myeloma cells by leveraging the immune system, offering a therapeutic advantage and potentially improving patient outcomes when used as part of a comprehensive cancer treatment plan.
Q: When should Darzalex Daratumumab injections be given?
A: The timing and frequency of administration are decided by your oncologist, commonly at regular intervals within a treatment cycle. Adherence to the prescribed schedule is vital for optimal effectiveness.
Q: Where should I store Darzalex Daratumumab injection vials before use?
A: Vials must be stored in a refrigerator at temperatures between 2C and 8C, protected from light by keeping them in the outer carton. Do not freeze the vials.
Q: What precautions should be taken during the handling and preparation process?
A: Only qualified healthcare professionals should handle and prepare the injection, using aseptic techniques. The vial contents must be diluted with 0.9% sodium chloride injection. Always inspect the solution for particulates or discoloration before administration.
Q: Is a prescription required to obtain Darzalex Daratumumab 100 mg Injection?
A: Yes, this medication is only available by prescription and must be administered by a healthcare professional experienced in cancer therapy.